Sintx Technologies (SINT) Assets Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.87% |
| Dec 31, 2025 | -15.53% |
| Sep 30, 2025 | -7.94% |
| Jun 30, 2025 | -19.30% |
| Mar 31, 2025 | -15.36% |
| Dec 31, 2024 | -24.46% |
| Sep 30, 2024 | -23.11% |
| Jun 30, 2024 | -16.65% |
| Mar 31, 2024 | -15.09% |
| Dec 31, 2023 | -20.38% |
| Sep 30, 2023 | -21.96% |
| Jun 30, 2023 | -8.07% |
| Mar 31, 2023 | 13.82% |
| Dec 31, 2022 | 19.92% |
| Sep 30, 2022 | 11.18% |
| Jun 30, 2022 | 15.76% |
| Mar 31, 2022 | 22.56% |
| Dec 31, 2021 | 23.78% |
| Sep 30, 2021 | 19.98% |
| Jun 30, 2021 | 5.33% |
| Mar 31, 2021 | 24.63% |
| Dec 31, 2020 | 27.64% |
| Sep 30, 2020 | 16.57% |
| Mar 31, 2020 | -16.17% |
| Dec 31, 2019 | -29.64% |
| Sep 30, 2019 | -30.40% |
| Jun 30, 2019 | -25.71% |
| Dec 31, 2018 | -31.52% |
| Sep 30, 2018 | -27.12% |
| Jun 30, 2018 | -17.30% |
| Mar 31, 2018 | -30.25% |
| Dec 31, 2017 | -32.49% |
| Sep 30, 2017 | -21.35% |
| Mar 31, 2017 | -15.90% |
| Dec 31, 2016 | -8.54% |